Earnings History Data for Karuna Therapeutics, Inc. (KRTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Karuna Therapeutics, Inc.
Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's product candidate consists of KarXT, for the treatment of acute psychosis in patients with schizophrenia, which are in clinical stage. Karuna Therapeutics Inc. is based in Boston, Massachusetts.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02-11-2023 | PM | KRTX | Karuna Therapeutics, Inc. | 6,280 | -3.16 | -2.74 | -2.38 | Karuna Therapeutics GAAP EPS of -$3.16 misses by $0.40 [11/2/2023 6:47 AM] |
169.14 | -4.04 (-2.33%) |
169.14 | 0.0 (0.00%) |
158.38 - 245.00 | 255,761 | 210,000 | 3,522 | ||
| 03-08-2023 | PM | KRTX | Karuna Therapeutics, Inc. | 7,380 | -2.75 | -2.76 | -2.17 | Karuna Therapeutics GAAP EPS of -$2.75 beats by $0.09 [8/3/2023 7:30 AM] |
186.79 | -10.91 (-5.52%) |
186.79 | 0.0 (0.00%) |
125.09 - 278.25 | 776,114 | 240,000 | 2,653 | ||
| 04-05-2023 | PM | 6:30 AM ET (May 4) |
KRTX | Karuna Therapeutics, Inc. | 7,540 | -2.80 | -2.86 | -1.95 | Karuna Therapeutics GAAP EPS of -$2.80 misses by $0.01, revenue of $0.65M [5/4/2023 6:32 AM] |
206.33 | -4.07 (-1.93%) |
213.00 | 2.60 (1.24%) |
92.26 - 278.25 | 299,352 | 360,000 | 519 | |
| 08-08-2022 | PM | KRTX | Karuna Therapeutics | 4,016 | -2.17 | -2.02 | 0.00 | Karuna Therapeutics GAAP EPS of -$2.17 misses by $0.10, revenue of $5.28M [8/8/2022 6:43 AM] |
240.84 | 100.48 (71.59%) |
221.89 | 81.53 (58.09%) |
92.26 - 245.00 | 3,633,822 | 290,000 | 585,947 | ||
|
||||||||||||||||||
| 05-08-2021 | PM | KRTX | Karuna Therapeutics, Inc. | 3,360 | -1.17 | -1.24 | -0.65 | Karuna Therapeutics EPS beats by $0.12 [8/5/2021 7:39 AM] |
117.28 | 9.47 (8.78%) |
107.81 | 0.0 (0.00%) |
69.58 - 146.97 | 239,187 | 160,000 | 1,340 | ||
| 06-05-2021 | PM | 6:00 AM ET (May 6) |
KRTX | Karuna Therapeutics, Inc. | 3,290 | -1.10 | -1.06 | -0.33 | Karuna Therapeutics EPS in-line [5/6/2021 6:40 AM] |
111.60 | 4.05 (3.77%) |
111.60 | 0.0 (0.00%) |
69.58 - 146.97 | 159,101 | 120,000 | 778 | |
| 05-11-2020 | PM | KRTX | Karuna Therapeutics, Inc. | 2,460 | -0.71 | -0.76 | -0.39 | Karuna Therapeutics EPS beats by $0.07 [11/5/2020 6:08 AM] |
102.73 | 3.22 (3.24%) |
102.73 | 0.0 (0.00%) |
15.12 - 152.00 | 115,407 | 165,658 | 1,372 | ||
|
|
||||||||||||||||||